Learn More
Medchemexpress LLC 6-(3,4-dichlorobenzamido)-N-(thiazol-2-yl)-2-naphthamide | 2247919-28-2 | 98.1% | 442.32 g/mol | C21H13Cl2N3O2S | 5MG

Supplier: Medchemexpress LLC HY1262495MG
AAPK-25 is a potent, selective dual inhibitor of Aurora kinases and Polo-like kinases (PLK) used in preclinical research to investigate cell cycle regulation and anticancer mechanisms. It causes mitotic delay and arrests cells in prometaphase, and is provided as a solid or as a DMSO solution for cellular and biochemical assays.
- Potent dual inhibitor of Aurora kinases and PLK.
- Induces mitotic delay and prometaphase arrest in cells.
- Suitable for cellular and biochemical kinase assays.
- High purity (98.1%) for research applications.
- Available in solid and solution formats for flexible use.
- Simple storage guidance for sample stability in solution and solid forms.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.